Rheumatology Month in Review: April 2024
This month's review showcases the ongoing efforts to enhance patient care through innovative treatments and comprehensive management strategies.
Stay updated with breaking news from Psoriasis Area. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This month's review showcases the ongoing efforts to enhance patient care through innovative treatments and comprehensive management strategies.
Treatment with risankizumab was shown to be an effective strategy among patients with PsA regardless of varying demographic and psoriatic disease characteristics through 1 year.
A new study found intensive topical therapy improves deep sleep and REM sleep for patients with psoriasis and atopic dermatitis after 2 weeks.
Post-treatment with risankizumab, the cDAPSA score, PGA score, and PASI score substantially decreased among a cohort of patients with psoriatic arthritis.
Growing evidence suggests a link between the gut microbiota and atopic dermatitis, psoriasis, acne vulgaris, and alopecia areata.